L. Forsberg

发表

Menin interacts directly with the homeobox-containing protein Pem.

C. Larsson, F. Piehl, W. V. D. Van de Ven, 2001, Biochemical and biophysical research communications.

Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue

C. Larsson, A. Gill, A. Conigrave, 2008, Molecular and Cellular Endocrinology.

Electrical short-circuit in β-cells from a patient with non-insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a case report

P. Berggren, E. Berglund, L. Grimelius, 2010, Journal of medical case reports.

Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)

J. Carpten, C. Larsson, B. Teh, 2004, Journal of Medical Genetics.

Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.

C. Larsson, F. Farnebo, L. Farnebo, 2001, Kidney international.

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

C. Larsson, Amy Y. M. Au, W. Lui, 2006, The Journal of clinical endocrinology and metabolism.

On 13 q 14 deletions in chronic lymphocytic leukemia

C. Larsson, D. Grandér, D. Oscier, 2008 .

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome

J. Carpten, E. Gillanders, J. Trent, 2002, Nature Genetics.

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

C. Larsson, K. Sandelin, A. Höög, 2009, International journal of oncology.

BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner.

Å. Sjöholm, Fan Zhang, R. Bränström, 2009, American journal of physiology. Cell physiology.

Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.

C. Larsson, J. Hashemi, M. Reimers, 2005, European journal of endocrinology.

Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism.

T. Dwight, C. Larsson, B. Teh, 2002, European journal of endocrinology.

Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism.

C. Larsson, S. Lagercrantz, F. Farnebo, 2001, European journal of endocrinology.

Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid.

C. Larsson, E. Berglund, G. Westin, 2010, Journal of molecular endocrinology.

Pre-fractionation of archival frozen tumours for proteomics applications.

C. Larsson, R. Lewensohn, J. Lehtiö, 2006, Journal of biotechnology.

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.

C. Larsson, K. Sandelin, J. Nordenström, 2007, Endocrine-related cancer.

Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.

C. Larsson, L. Farnebo, S. Välimäki, 2002, International journal of oncology.

DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse

C. Larsson, D. Grandér, D. Oscier, 2004, Genes, chromosomes & cancer.

Characterization of chromosomal abnormalities in uroepithelial carcinomas by G‐banding, spectral karyotyping and FISH analysis

C. Larsson, U. Bergerheim, W. Lui, 2001, International journal of cancer.

Evidence for Presence and Functional Effects of Kv1.1 Channels in beta-Cells: General Survey and Results from mceph/mceph Mice

F. Sundler, N. Wierup, E. Berglund, 2011 .